Risk factors for failure of Helicobacter pylori eradication therapy

This publication has 14 references indexed in Scilit:

• Effect of Pretreatment Antibiotic Resistance to Metronidazole and Clarithromycin on Outcome of Helicobacter pylori Therapy
  Digestive Diseases and Sciences, 2000
• A systematic review of Helicobacter pylori eradication therapy—the impact of antimicrobial resistance on eradication rates
  Alimentary Pharmacology & Therapeutics, 1999
• The Influence of in Vitro Nitroimidazole Resistance on The Efficacy of Nitroimidazole-Containing Anti- Helicobacter Pylori Regimens: A Meta-Analysis
  American Journal of Gastroenterology, 1999
• The role of the rdxA gene in the evolution of metronidazole resistance in Helicobacter pylori
  Journal of Antimicrobial Chemotherapy, 1999
• Differences between the activity of penicillin, amoxycillin, and co-amoxyclav against 5,252 Streptococcus pneumoniae isolates tested in the Alexander Project 1992- 1996
  Journal of Antimicrobial Chemotherapy, 1999
• Direct detection of Helicobacter pylori resistance to macrolides by a polymerase chain reaction/DNA enzyme immunoassay in gastric biopsy specimens
  Gut, 1999
• The MACH2 study: Role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies
  Gastroenterology, 1999
• Macrolide resistance in Helicobacter pylori: rapid detection of point mutations and assays of macrolide binding to ribosomes
  Antimicrobial Agents and Chemotherapy, 1997
• Eradication of Helicobacter pylori Using One‐week Triple Therapies Combining Omeprazole with Two Antimicrobials: The MACH I Study
  Helicobacter, 1996
• Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies.
  Journal of Clinical Pathology, 1988